Accurate identification of paraprotein antigen targets by epitope reconstruction

Blood

Volumn 111, Issue 1, 2008, Pages 302-308

  Sompuram, Seshi R ^a,b   Bastas, Gerassimos ^b   Vani, Kodela ^a   Bogen, Steven A ^a,b  

^a Medical Discovery Partners LLC   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; PARAPROTEIN;

AMINO ACID SEQUENCE; ANALYTIC METHOD; ANTIGEN DETECTION; ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS; EPITOPE MEDIATED ANTIGEN PREDICTION; HUMAN; HUMAN TISSUE; IMMUNOASSAY; IMMUNOBLOTTING; IMMUNOSTIMULATION; MULTIPLE MYELOMA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; TECHNOLOGY;

EID: 38049139193     PISSN: 00064971     EISSN: 00064971     Source Type: Journal    
DOI: 10.1182/blood-2007-05-090654     Document Type: Article

References (26)

1. Dybwad A, Lambin P, Sioud M, Zouali M. Probing the specificity of human myeloma proteins with a random peptide phage library. Scand J Immunol. 2003;57:583-590.
2. Szecsi PB, Riise E, Roslund LB, et al. Identification of patient-specific peptides for detection of M-proteins and myeloma cells. Br J Haematol. 1999;107:357-364.
3. Thurnheer M, Zuercher A, Miescher S, Rudolf M, Vogel M, Stadler B. Molecular mimicry of the unidentified antigen of myeloma antibody IgE-ND. Eur J Immunol. 1999;29:2676-2683.
4. Zonder J, Tainsky M, Stone M, Konduri K, Oliver J, Ratner S. Myeloma paraprotein epitope identification using a phage library of sterically constrained peptides. Paper presented at the American Society of Clinical Oncology Annual Meeting. 2005.
5. Bastas G, Sompuram SR, Pierce B, Vani K, Bogen SA. Bioinformatic requirements for protein database searching using predicted epitope from disease-associated antibodies. Mol Cell Proteomics. 2007 Sep 25 [Epub ahead of print].
6. Sompuram S, Kodela V, Ramanathan H, Wescott C, Radcliffe G, Bogen S. Synthetic peptides identified from phage-displayed combinatorial libraries as immunodiagnostic assay surrogate quality control targets. Clin Chem. 2002;48:410-420.
7. Sompuram S, Kodela V, Zhang K, et al. A novel quality control slide for quantitative immunohistochemistry testing. J Histochem Cytochem. 2002;50:1425-1434.
8. Sompuram S, Vani K, Messana E, Bogen S. A molecular mechanism of formalin fixation and antigen retrieval. Amer J Clin Pathol. 2004;121:190-199.
9. Bailey TL, Baker ME, Elkan CP. An artificial intelligence approach to motif discovery in protein sequences: application to steroid dehydrogenases. J Steroid Biochem Mol Biol. 1997;62:29-44.
10. Bossuyt X, Bogaerts A, Schiettekatte G, Blanckaert N. Serum protein electrophoresis and immunofixation by a semiautomated electrophoresis system. Clin Chem. 1998;44:944-999.
11. Bailey T, Elkan C. Fitting a mixture model by expectation maximization to discover motifs in biopolymers. In: Proceedings of the Second International Conference on Intelligent Systems for Molecular Biology. Menlo Park, CA: AAAI Press; 1994:28-36.
12. Bailey T, Gribskov M. Combining evidence using p-values: application to sequence homology searches. Bioinformatics. 1998;14:48-54.
13. Nooija F, Van der Sluijs-Gellingb A, Jol-Van der Zijde C, Van Tolc M, Haasd H, Radl J. Immunoblotting techniques for the detection of low level homogeneous immunoglobulin components in serum. J Immunol Methods. 1990;134:273-281.
14. Knisley K, Rodkey L. Affinity immunoblotting: high resolution isoelectric focusing analysis of antibody clonotype distribution. J Immunol Methods. 1986;95:79-87.
15. Jin D, Nowakowski M, Kramer M, Essex D. Hyperviscosity syndrome secondary to a myeloma-associated IgG1k paraprotein strongly reactive against the HIV-1 p24 gag antigen. Am J Hematol. 2000;64:210-213.
16. Kohler M, Daus H, Kohler C, Schlimmer P, Wernert N, Scheurlen P. Lymphocytic plasmacytoid lymphoma with a three-banded gammopathy: reactivity of one of these paraproteins with cytomegalovirus. Blut. 1987;54:25-32.
17. Waldenstrom J, Winblad S, Hallen J, Liungman S. The occurrence of serological "antibody" reagins or similar g-globulins in conditions with monoclonal hypergammaglobulinemia, such as myeloma, macroglobulinemia etc. Acta Medica Scandinavica. 1964;176:619-631.
18. Seligmann M, Danon F, Basch A, Bernard J. IgG myeloma cryoglobulin with antistretolysin activity. Nature. 1968;220.
19. Buhler S, Laitinen K, Holthofer H, Jarvinen A, Schauman K-O, Hedman K. High rate of monoclonal gammopathy among immunocompetent subjects with primary cytomegalovirus infection. Clin Infec Dis. 2002;35:1430-1433.
20. Vodopick H, Chaskes S, Solomon A, Stewart J. Transient monoclonal gammopathy associated with cytomegalovirus infection. Blood. 1974;44:189-195.
21. Wills M, Carmichael A, Mynard K, et al. The human cytotoxic T lymphocyte (CTL) response to cytomegalovirus is dominated by structural protein pp65: frequency, specificity, and T cell receptor usage of pp65-specific CTL. J Virol. 1996;70:7569-7579.
22. Komatsu H, Sierro S, Cuero A, Klenerman P. Population analysis of antiviral T cell responses using MHC class I-peptide tetramers. Clin Exp Immunol. 2003;134:9-12.
23. Khan N, Shariff N, Cobbold M, et al. Cytomegalovirus seropositivity drives the CD8 T cell repertoire toward greater clonality in healthy elderly individuals. J Immunol. 2002;169:1984-1992.
24. + T-cell responses to human cytomegalovirus reveals broad and multispecific reactivities in healthy virus carriers. J Virol. 2003;77:5226-5240.
25. Sissons J, Bain M, Wills M, Sinclair J. Latency and reactivation of human cytomegalovirus. J Infec. 2002;44:73-77.
26. Soderberg-Naucler C. Does cytomegalovirus play a causative role in the development of various inflammatory diseases and cancer? J Intern Med. 2006;259:219-246.